Tricyclic compounds and its use as tyrosine kinase modulators

Details for Australian Patent Application No. 2007284542 (hide)

Owner Chembridge Research Laboratories, Inc.

Inventors Vavilala, Goverdhan Reddy; Gantla, Vidyasagar Reddy; Jiang, Luyong; Thiruvazhi, Mohan Santhanam; Kadushkin, Alexander; Gregor, Vlad Edward; Zhu, Tong; Chucholowski, Alexander; McGrath, Douglas Eric; Zozulya, Sergey; Anikin, Alexey; Pickens, Jason C.; Webb, Thomas R.; Mikel, Charles; Vairagoundar, Rajendran; Yan, Zheng; Liu, Yahua; McGee, Danny Peter Claude

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007284542

PCT Pub. Number WO2008/021369

Priority 60/837,652 14.08.06 US

Filing date 13 August 2007

Wipo publication date 21 February 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4188 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 April 2009 PCT application entered the National Phase

  PCT publication WO2008/021369 Priority application(s): WO2008/021369

11 June 2009 Assignment before Grant

  Chembridge Research Laboratories, Inc. The application has been assigned to Chembridge Corporation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007284548-Modulators of muscarinic receptors

2007284537-Triazole compounds that modulate HSP90 activity